In this issue, several aspects of dermatological treatment have been presented.
In the sections “Psoriasis” and “Atopic dermatitis”, Goeckerman treatment (a time-honored old modality for treating psoriasis) is discussed. In modern times of pathogenesis-based treatments, the question is whether we still need this modality and if so when and in which patients.
In these two sections, the patient's perspective is highlighted. In situations where there is a choice between more than one course of treatment, the patient's perspective can help in maximizing the value of healthcare. The prescription patterns reflect to a large extent this interaction. But of course in patient adherence the commitment of the patient in the therapeutic process is the conditio sine qua non. In the section on psoriasis, the authors have focused on demyelinating diseases as a potential side effect.
The section “Psychodermatology” discusses several publications relevant to measuring quality of life and adherence to treatment.
Skin infections comprise a large part of dermotological consultations. In this issue, one would find some aspects of treatment of erythrasma and onychomycosis.